Introduction: Triple-A syndrome (Triple-A) is an autosomal recessive disorder characterized by alacrimia, achalasia, and adrenal insufficiency. Several variants on the AAAS gene have been described, and some variants are clustered in particular geographical areas, such as the c.1331+1G>A variant which is very frequent in North Africa. Here, we describe the genetic features of Triple-A in a series of unrelated families from Morocco. Methods: Screening for the AAAS c.1331+1G>A variant was performed by direct sequencing or by PCR-RFLP. Haplotype analysis using Single Tandem Repeat (STR) markers flanking AAAS gene was performed in order to evaluate the founder effect and estimate the age of the c.1331+1G>A variant. Results: Seven unrelated families with ten individuals clinically diagnosed with Triple-A were evaluated for sequence variations in the AAAS gene. The median age at diagnosis was 3 years, with a range between 2 and 11 years. Molecular analysis revealed that all patients were homozygous for the c.1331+1G>A variant. This variant was not found in 200 healthy controls, indicating that carriers are very rare in the general Moroccan population. Subsequently, STR marker analysis revealed a founder effect and that the most recent common ancestor of Triple-A patients in Morocco would have lived 125 years ago. Conclusion: This is the largest series of Triple-A in Morocco. The same AAAS c.1331+1G>A variant was found in all patients, suggesting a founder effect in Morocco which was subsequently confirmed by microsatellite marker analysis. Therefore, this variant should be systematically investigated to diagnose Triple-A in Morocco.

1.
Achargui M, Azhrai R, Harrar Y, Mabrouki F, Chariba S, Maadane A, et al. Alacrimia revealing triple A syndrome: a case report. Asian J Ophthalmol Case Rep. 2023;6:24–8.
2.
Alakeel A, Raynaud C, Rossi M, Reix P, Jullien D, Souillet AL. Syndrome d’Allgrove. Ann Dermatol Venereol. 2015;142(2):121–4.
3.
Allgrove J, Clayden G, Grant D, Macaulay J. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet. 1978;1(8077):1284–6.
4.
Amrani R, Es-seddiki A, Ayyad A, Messaoudi S, Tazi N. Syndrome d’Allgrove découvert sur une anémie ferriprive chez un enfant de 3 ans. Pan Afr Med J. 2014;19.
5.
Barat P, Goizet C, Tullio‐Pelet A, Puel O, Labessan C, Barthelemy A. Phenotypic heterogeneity in AAAS gene mutation. Acta Paediatr. 2004;93(9):1257–9.
6.
Cherif Ben Abdallah L, Lakhoua Y, Nagara M, Khiari K, Elouej S, Messaoud O, et al. A tunisian patient with two rare syndromes: triple a syndrome and congenital hypogonadotropic hypogonadism. Horm Res Paediatr. 2014;82(5):338–43.
7.
Berrani H, Meskini T, Zerkaoui M, Merhni H, Ettair S, Sefiani A, et al. Clinical and molecular report of c. 1331+ 1G[{GT}] A mutation of the AAAS gene in a Moroccan family with Allgrove syndrome: a case report. BMC Pediatr. 2018;18:184–4.
8.
Brooks B, Kleta R, Stuart C, Tuchman M, Jeong A, Stergiopoulos SG, et al. Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000–2005. Clin Genet. 2005;68(3):215–21.
9.
Brown B, Agdere L, Muntean C, David K. Alacrima as a harbinger of Adrenal insufficiency in a child with Allgrove (AAA) syndrome. Am J Case Rep. 2016;17:703–6.
10.
Chang AJ, Kline MM, Currie Y, Perez MO, Hartiala J, Wijesuriya H, et al. Allgrove syndrome in a Mexican American family is caused by an ancestral mutation derived from North Africa. Clin Genet. 2008;73(4):385–7.
11.
Derrar R, Boutimzine N, Laghmari A, Alouane A, Daoudi R. Alacrymie congénitale révélant un syndrome d’Allgrove: à propos de trois cas. Pan Afr Med J. 2015;20:359.
12.
Flokas ME, Tomani M, Agdere L, Brown B. Triple A syndrome (Allgrove syndrome): improving outcomes with a multidisciplinary approach. Pediatr Health Med Ther. 2019;10:99–106.
13.
Gaiani F, Gismondi P, Minelli R, Casadio G, de’Angelis N, Fornaroli F, et al. Case report of a familial triple: a syndrome and review of the literature. Medicine. 2020;99(22):e20474.
14.
Geiculescu I, Dranove J, Cosper G, Edmondson AC, Morava-Kozicz E, Carter LB. A rare cause of infantile achalasia: GMPPA-congenital disorder of glycosylation with two novel compound heterozygous variants. Am J Med Genet. 2022;188(8):2438–42.
15.
Genin E, Tullio-Pelet A, Begeot F, Lyonnet S, Abel L. Estimating the age of rare disease mutations: the example of Triple-A syndrome. J Med Genet. 2004;41(6):445–9.
16.
Ghaheri M, Kahrizi D, Yari K, Babaie A, Suthar R, Kazemi E. A comparative evaluation of four DNA extraction protocols from whole blood sample. Cell Mol Biol. 2016;62(3):120–4.
17.
Hadj-Rabia S, Salomon R, Pelet A, Penet C, Rotschild A, de Laët MH, et al. Linkage disequilibrium in inbred North African families allows fine genetic and physical mapping of triple A syndrome. Eur J Hum Genet. 2000;8:613–20.
18.
Handschug K, Sperling S, Yoon S-JK, Hennig S, Clark AJ, Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet. 2001;10(3):283–90.
19.
Kallabi F, Belghuith N, Aloulou H, Kammoun T, Ghorbel S, Hajji M, et al. Clinical and genetic characterization of 26 Tunisian patients with Allgrove syndrome. Arch Med Res. 2016a;47(2):105–10.
20.
Kallabi F, Ben Rebeh I, Felhi R, Sellami D, Masmoudi S, Keskes L, et al. Molecular analysis of Libyan families with Allgrove syndrome: geographic expansion of the ancestral mutation c.1331+1G[{GT}]A in North Africa. Horm Res Paediatr. 2016b;85(1):18–21.
21.
Kallabi F, Ben Rhouma B, Baklouti S, Ghorbel R, Felhi R, Keskes L, et al. Splicing defects in the AAAS gene leading to both exon skipping and partial intron retention in a Tunisian patient with Allgrove syndrome. Horm Res Paediatr. 2016c;86(2):90–3.
22.
Kallabi F, Tebaibia A, Boudjella L, Mahfoudh N, Kamoun A, Gaddour L, et al. Effet fondateur et estimation de l’âge de la mutation fondatrice dans trois pays maghrébins: à propos de 66 patients atteints du syndrome d’Allgrove. Ann Endocrinol. 2016d;77(4):309–10.
23.
Koehler K, Milev MP, Prematilake K, Reschke F, Kutzner S, Jühlen R, et al. A novel TRAPPC11 mutation in two Turkish families associated with cerebral atrophy, global retardation, scoliosis, achalasia and alacrima. J Med Genet. 2017;54(3):176–85.
24.
Lanes R, Plotnick LP, Bynum TE, Lee PA, Casella JF, Fox CE, et al. Glucocorticoid and partial mineralocorticoid deficiency associated with achalasia. J Clin Endocrinol Metab. 1980;50(2):268–70.
25.
Lhousni S, Belmokhtar KY, Belmokhtar I, Elidrissi Errahhali M, Elidrissi Errahhali M, et al. Morocco’s first Biobank: establishment, ethical issues, biomedical research opportunities, and challenges. BioMed Res Int. 2020:2020.
26.
Lorea CF, Tenório RB, Koenig M, Huebner A, Koehler K, Devos D, et al. Neurological phenotypes associated with AAAS-related disorders: spastic ataxia and complex spastic paraplegia. Cerebellum. 2020;19(3):465–8.
27.
Milenković T, Koehler K, Krumbholz M, Zivanović S, Zdravković D, Huebner A. Three siblings with triple A syndrome with a novel frameshift mutation in the AAAS gene and a review of 17 independent patients with the frequent p.Ser263Pro mutation. Eur J Pediatr. 2008;167(9):1049–55.
28.
Nebel A, Landau-Tasseron E, Filon D, Oppenheim A, Faerman M. Genetic evidence for the expansion of arabian tribes into the southern levant and North Africa. Am J Hum Genet. 2002;70(6):1594–6.
29.
Patt H, Koehler K, Lodha S, Jadhav S, Yerawar C, Huebner A, et al. Phenotype–genotype spectrum of AAA syndrome from Western India and systematic review of literature. Endocr Connect. 2017;6(8):901–13.
30.
Pogliaghi G, Cangiano B, Duminuco P, Vezzoli V, Bonomi M. Triple-A Syndrome (TAS): an in-depth overview on genetic and phenotype heterogeneity. Protein Pept. 2020;27(12):1192–203.
31.
Sandrini F, Farmakidis C, Kirschner LS, Wu S-M, Tullio-Pelet A, Lyonnet S, et al. Spectrum of mutations of the AAAS gene in Allgrove syndrome: lack of mutations in six kindreds with isolated resistance to corticotropin. J Clin Endocrinol Metab. 2001;86(11):5433–7.
32.
Sarathi V, Shah NS. Triple-A Syndrome. Diseases of DNA Repair; 2010. p. 1–8.
33.
Singh K, Puri RD, Bhai P, Arya AD, Chawla G, Saxena R, et al. Clinical heterogeneity and molecular profile of triple A syndrome: a study of seven cases. J Pediatr Endocrinol Metab. 2018;31(7):799–807.
34.
Thümmler S, Huebner A, Baechler-Sadoul E. Triple A syndrome: two novel mutations in the AAAS gene. BMJ Case Rep. 2009;2009(apr07 1):bcr0920080984.
35.
Tibussek D, Ghosh S, Huebner A, Schaper J, Mayatepek E, Koehler K. Crying without tears” as an early diagnostic sign-post of triple A (Allgrove) syndrome: two case reports. BMC Pediatr. 2018;18:6–5.
36.
Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet M-H, Chaouachi B, et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet. 2000;26(3):332–5.
37.
Vaezi MF, Felix VN, Penagini R, Mauro A, de Moura EGH, Pu LZCT, et al. Achalasia: from diagnosis to management. Ann N Y Acad Sci. 2016;1381(1):34–44.
38.
Yassaee VR, Soltani Z, Ardakani BM. Mutation spectra of the AAAS gene in Iranian families with Allgrove Syndrome. Arch Med Res. 2011;42(2):163–8.
39.
Yuksel B, Braun R, Topaloglu AK, Mungan NO, Ozer G, Huebner A. Three children with triple A syndrome due to a mutation (R478X) in the AAAS gene. Horm Res. 2004;61(1):3–6.
You do not currently have access to this content.